γδ T cells as unconventional targets of checkpoint blockade

IF 23.5 1区医学 Q1 ONCOLOGY

Nature cancer Pub Date : 2024-03-27 DOI:10.1038/s43018-024-00735-y

Hans R. Widlund, Lydia Lynch

引用次数: 0

Abstract

Identifying which patients will benefit most from immune checkpoint blockade (ICB) is an important clinical challenge. A study now finds that Vδ1+ γδ T cells are associated with better response to ICB in melanoma tumors with a lower neoantigen load and shows that some effector functions of PD-1+ Vδ1+ T cells are repressed after engagement of PD-1 by PD-L1.

Abstract Image

查看原文本刊更多论文

γδT细胞是检查点阻断的非常规靶点。

确定哪些患者将从免疫检查点阻断疗法（ICB）中获益最多是一项重要的临床挑战。现在的一项研究发现，在新抗原负荷较低的黑色素瘤肿瘤中，Vδ1+ γδ T细胞与更好的ICB反应相关，并表明PD-1+ Vδ1+ T细胞的某些效应功能在PD-1与PD-L1接合后受到抑制。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature cancer Medicine-Oncology

CiteScore

31.10

自引率

1.80%

发文量

129

期刊介绍： Cancer is a devastating disease responsible for millions of deaths worldwide. However, many of these deaths could be prevented with improved prevention and treatment strategies. To achieve this, it is crucial to focus on accurate diagnosis, effective treatment methods, and understanding the socioeconomic factors that influence cancer rates. Nature Cancer aims to serve as a unique platform for sharing the latest advancements in cancer research across various scientific fields, encompassing life sciences, physical sciences, applied sciences, and social sciences. The journal is particularly interested in fundamental research that enhances our understanding of tumor development and progression, as well as research that translates this knowledge into clinical applications through innovative diagnostic and therapeutic approaches. Additionally, Nature Cancer welcomes clinical studies that inform cancer diagnosis, treatment, and prevention, along with contributions exploring the societal impact of cancer on a global scale. In addition to publishing original research, Nature Cancer will feature Comments, Reviews, News & Views, Features, and Correspondence that hold significant value for the diverse field of cancer research.